Research Groups and R&D Platforms: Diagnostics, Personalized medicine
Research Group:
Systems Medicine
Matej Oresic
matej.oresic[at]utu.fi
Turku Bioscience Centre,
University of Turku
Assay development, Autoimmune diseases, Bioinformatics, Biomarker, Diabetes, Diagnostics, Metabolic diseases, Metabolomics, Molecular diagnostics, Obesity, Personalized medicine, Systems Biology
Research Group:
Cell fate – from molecular understanding to control
Cecilia Sahlgren
cecilia.sahlgren[at]abo.fi, cecilia.sahlgren[at]bioscience.fi
Turku Bioscience Centre and
Faculty of Science and Engineering,
Åbo Aakdemi University
Atomic-force microscopy, Basic research, Biochemistry, Biomarker, Biotechnology, Breast cancer, Cancer, Cardiovascular diseases, Data mining, Developmental disorders, Diagnostics, Disease models, Drug delivery, Drug target, Imaging, Imaging software, In Vivo Diagnostics, Molecular Cell Biology, Molecular modelling, Personalized medicine, PET, Proteomics, Receptor, Signaling, Super-resolution imaging, Target discovery
Research Group:
Alpha2-Adrenoceptors as targets for drug development
Mika Scheinin
mschein[at]utu.fi
University of Turku, Turku University Hospital and CRST Oy
Clinical Research Services Turku
Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery
Research Group:
Genetic predisposition to cancer
Johanna Schleutker
Johanna.Schleutker[at]utu.fi
Institute of Biomedicine,
University of Turku
Antibodies, Assay development, Bioinformatics, Biomarker, Biomedicine, Biotechnology, Breast cancer, Cancer, Clinical Medicine, Data mining, Diagnostics, Epidemiology, Genetics, Genomics, In Vitro Diagnostics, Inherited diseases, Machine learning, Molecular Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Point of care, Prostate cancer, Screening
Research Group:
Cancer Cell Signaling
Jukka Westermarck
jukwes[at]utu.fi
Turku Bioscience Centre and Institute of Biomedicine,
University of Turku
Assay development, Basic research, Biochemistry, Biomarker, Biomedicine, Breast cancer, Cancer, Colorectal cancer, Data mining, Diagnostics, Disease models, Drug delivery, Genomics, Lung cancer, Molecular Biology, Molecular Cell Biology, Nanoparticles, Next-generation sequencing, Pathology, Personalized medicine, Prostate cancer, Proteomics, Receptor, Screening, Signaling, Squamous cell carcinoma, Systems Biology, Target discovery, X-ray crystallography
Research Group:
Valorisation of biomass using molecular process technology
Stefan Willför
swillfor[at]abo.fi
Laboratory of Wood and Paper Chemistry,
Åbo Akademi University
Antibacterial, Biopharmaceuticals, Diagnostics, Drug solubility, Drug stability, Electron microscopy, Hit to lead, MALS or SEC-MALS, Natural Compounds, Natural products, NMR, Organic Chemistry, Organic compounds, Particle size analysis, Personalized medicine, Physico-chemical properties, Porosity, Surface area, Synthetic chemistry, Thermal analysis
